Issues related to drug pricing; Issues related to cardiovascular disease awareness and treatment.
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- SIGHTLINE ADVOCACY, LLC
- Client
- AMGEN
- Filing UUID
- 03e566d5-1711-428d-aba7-b2978b476751
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.